Study Stopped
due to covid19 pandemic
Acupuncture Treatment for Improving Alzheimer's Dementia
Clinical Trial to Measure Efficacy of Acupuncture Treatment for Alzheimer's Dementia as Measured by MOCA(Montreal Cognitive Assessment)
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Evaluate cognitive improvement pre amd post acupuncture treatment in patients with probable alzheimer's dementia as measured by MOCA score and also per form A( measure of patient's personal information). Also caregiver input.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2015
CompletedFirst Posted
Study publicly available on registry
August 21, 2019
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
October 12, 2022
October 1, 2022
2 years
April 28, 2015
October 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement on Montreal Cognitive Assessment test of 5 points or more than baseline( total score is out of 30 points)
Subject will complete 3 MOCA assessment prior to study over 1 week time. Best score of three is used. After study is complete subject will also undergo 3 MOCA assessment over 1 week immediately after study. Again best score is used.
12 weeks
Secondary Outcomes (1)
Improvement of Montreal Cognitive Assessment test by category than raw total score
12 weeks
Study Arms (1)
Acupuncture
EXPERIMENTALAcupuncture 12 sessions over 6 week to be given to pateints
Interventions
Patient will receive 12 acupuncture treatments over 6 weeks (2x per week)
Eligibility Criteria
You may qualify if:
- Mild to moderate AD
You may not qualify if:
- Severe AD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SANJAY CHAUHAN, M.D.
N & S Neurology Center, A Medical Group, Inc
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2015
First Posted
August 21, 2019
Study Start
January 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
October 12, 2022
Record last verified: 2022-10